Mechanisms of acquired resistance against immunotherapy

Do We Need to Differentiate Between Intrinsic and Acquired Resistance in Cancer?Подробнее

ITOG 3-23 | 02 | Mechanisms of acquired IO-resistance: What do we know (Perspective 1)?Подробнее

Describe acquired resistance mechanisms with OsimertinibПодробнее

Mechanisms of resistance to immunotherapy in NHLПодробнее

EGFR TKI Resistance: Progress and ChallengesПодробнее

Myeloid Cell Infiltration and Acquired Resistance to ImmunotherapyПодробнее

Frontiers in Oncology - Antoni Ribas, MD, PhDПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

CRSF 7th Masterclass | Dr. Gautam Goyal: Understanding Resistance Mechanisms to ImmunotherapyПодробнее

Acquired mechanisms of resistance to PD-(L)1 blockade in NSCLCПодробнее

Challenges to Precision Medicine for Anti-Cancer ImmunotherapyПодробнее

Colorectal Cancer with acquired resistance to EGFR antibodies: How to manage?Подробнее

James Allison, PhD - Immune Checkpoint Blockade in Cancer Therapy (2020)Подробнее

Immunotherapy Now and Future for Metastatic Renal Cell Carcinoma Jianjun Gao, MD, PhDПодробнее

Mechanisms of Resistance to EGFR TKI and New Treatment StrategiesПодробнее

Overcoming Acquired Resistance Mechanisms in BRAF+ mCRCПодробнее

Primary and Acquired Resistance to Cancer ImmunotherapyПодробнее

Dr. Paulson Discusses Acquired Resistance to ImmunotherapyПодробнее

Role of Genomics in Identifying Biomarkers for Response and Resistance to Anti-Cancer ImmunotherapyПодробнее